Geschäftskunden Kundenprogramme
Vor Ort
Merkzettel Warenkorb
Produktbild: Communicable Disease Control and Health Protection Handbook

Communicable Disease Control and Health Protection Handbook

Fr. 102.00

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.02.2012

Verlag

John Wiley & Sons Inc

Seitenzahl

454

Maße (L/B/H)

23.1/15.7/2 cm

Gewicht

770 g

Auflage

3. Auflage

Sprache

Englisch

ISBN

978-1-4443-3567-5

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.02.2012

Verlag

John Wiley & Sons Inc

Seitenzahl

454

Maße (L/B/H)

23.1/15.7/2 cm

Gewicht

770 g

Auflage

3. Auflage

Sprache

Englisch

ISBN

978-1-4443-3567-5

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Communicable Disease Control and Health Protection Handbook
  • Foreword.
    Abbreviations.
    Section 1: Introduction.
    1.1 How to use this book.
    1.2 Basic Concepts in the Epidemiology and Control of Infectious Disease.
    1.3 Health Protection on-call.
    Section 2: Common topics.
    2.1 Meningitis and meningism.
    2.2 Gastrointestinal infection.
    2.3 Community acquired pneumonia.
    2.4 Rash in pregnancy.
    2.5 Rash and fever in children.
    2.6 Illness in returning travellers.
    2.7 Sexually Transmitted Infections.
    2.8 Jaundice.
    2.9 Infection in the immunocompromised.
    2.10 Blood borne viral infections.
    2.11 Vaccine Queries.
    2.12 Individual measures against infections.
    Section 3: Diseases.
    3.1 Amoebic dysentery.
    3.2 Anthrax.
    3.3 Bacillus cereus.
    3.4 Botulism.
    3.5 Brucellosis.
    3.6 Burkholderia.
    3.7 Campylobacter.
    3.8 Chickenpox and shingles (varicella-zoster infections).
    3.9 Chikungunya.
    3.10 Chlamydophila pneumoniae.
    3.11 Chlamydophila psittaci.
    3.12 Chlamydia trachomatis (genital).
    3.13 Cholera.
    3.14 CJD and other human transmissible spongiform encephalopathies.
    3.15 Clostridium difficile.
    3.16 Clostridium perfringens.
    3.17 Coxsackievirus infections.
    3.18 Cryptosporidiosis.
    3.19 Cyclosporiasis.
    3.20 Cytomegalovirus.
    3.21 Dengue fever.
    3.22 Diphtheria.
    3.23 Encephalitis, acute.
    3.24 Enterococci, including glycopeptide-resistant enterococci (GRE).
    3.25 Epstein-Barr virus.
    3.26 Escherichia coli O157 (and other E. coli gastroenteritis).
    3.27 Giardiasis.
    3.28 Gonorrhoea, syphilis and other acute STIs.
    3.29 Hantavirus.
    3.30 Head lice.
    3.31 Helicobacter pylori.
    3.32 Hepatitis A.
    3.33 Hepatitis B.
    3.34 Hepatitis C.
    3.35 Delta hepatitis.
    3.36 Hepatitis E.
    3.37 Herpes simplex.
    3.38 Haemophilus influenzae type b (Hib).
    3.39 HIV.
    3.40 Influenza.
    3.41 Japanese B encephalitis.
    3.42 Kawasaki Syndrome.
    3.43 Legionellosis.
    3.44 Leprosy.
    3.45 Leptospirosis.
    3.46 Listeria.
    3.47 Lyme disease.
    3.48 Malaria.
    3.49 Measles.
    3.50 Meningococcal infection.
    3.51 Molluscum contagiosum.
    3.52 MRSA (methicillin-resistant Staphylococcus aureus).
    3.53 Mumps.
    3.54 Mycoplasma.
    3.55 Norovirus.
    3.56 Paratyphoid fever.
    3.57 Parvovirus B19 (fifth disease).
    3.58 Plague.
    3.59 Pneumococcal infection.
    3.60 Poliomyelitis.
    3.61 Q fever.
    3.62 Rabies.
    3.63 Relapsing Fever.
    3.64 Respiratory syncytial virus (RSV).
    3.65 Ringworm.
    3.66 Rotavirus.
    3.67 Rubella.
    3.68 Salmonellosis.
    3.69 Severe Acute Respiratory Syndrome (SARS).
    3.70 Scabies
    3.71 Shigella.
    3.72 Smallpox.
    3.73 Staphylococcal food poisoning.
    3.74 Streptococcal infections.
    3.75 Tetanus.
    3.76 Threadworms.
    3.77 Tick-borne encephalitis.
    3.78 Toxocara.
    3.79 Toxoplasmosis.
    3.80 Tuberculosis.
    3.81 Tularaemia.
    3.82 Typhoid fever.
    3.83 Rickettsial infections (incl. Typhus) Ehrlichia and Bartonella.
    3.84 Vibrio parahaemolyticus.
    3.85 Viral haemorrhagic fevers.
    3.86 Warts and verrucae.
    3.87 West Nile Virus.
    3.88 Whooping cough.
    3.89 Yellow fever.
    3.90 Yersiniosis.
    3.91 Other organisms.
    Section 4: Services and organisations.
    4.1 Surveillance of communicable disease.
    4.2 Managing infectious disease incidents and outbreaks.
    4.3 Infection Prevention and Control in the Community.
    4.4 Healthcare Associated Infection.
    4.5 Antimicrobial Resistance.
    4.6 Risks to and from Health Care Workers.
    4.7 Co-ordination of immunisation services.
    4.8 Services for sexual health and HIV infection.
    4.9 Services for tuberculosis control.
    4.10 Travel Health.
    4.11 Pandemic Preparedness and the Influenza A H1N1 2009 Pandemic.
    4.12 Non-infectious environmental hazards.
    4.13 Managing acute chemical incidents.
    4.14 Managing acute radiation incidents.
    4.15 Deliberate release of biological, chemical or radiological agents.
    4.16 Media Relations and Crisis Communication.
    4.17 Clinical Governance and Audit.
    4.18 Global health.
    Section 5: Communicable disease control in Europe.
    5.1 WHO and International Health Regulations (IHR).
    5.2 Collaboration within the European Union.
    5.3 Detailed national example: organisational a